Page last updated: 2024-08-24

halofuginone and AIDS-Related Opportunistic Infections

halofuginone has been researched along with AIDS-Related Opportunistic Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aboulafia, D; Cesarman, E; Dezube, BJ; Egorin, MJ; Fingleton, B; Geyer, JT; Koon, HB; Krown, SE; Lee, JY; Parise, RA	1

Trials

1 trial(s) available for halofuginone and AIDS-Related Opportunistic Infections

Article	Year
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. Journal of acquired immune deficiency syndromes (1999), 2011, Jan-01, Volume: 56, Issue:1 Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Piperidines; Quinazolinones; Sarcoma, Kaposi; Single-Blind Method; Young Adult	2011

Article

Year

Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.

Journal of acquired immune deficiency syndromes (1999), 2011, Jan-01, Volume: 56, Issue:1

Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Piperidines; Quinazolinones; Sarcoma, Kaposi; Single-Blind Method; Young Adult

2011